CDC25 phosphatase inhibitors

Details for Australian Patent Application No. 2001282234 (hide)

Owner Societe de Conseils de Recherches et D'Applications Scientifiques (S.C.R.A.S.)

Inventors Lanco, Christophe; Prevost, Gregoire; Galcera Contour, Marie-Odile; GoubinGramatica, Francoise; Thurieau, Christophe; Ducommun, Bernard; Brezak Pannetier, Marie-Christine

Agent Watermark

Pub. Number AU-B-2001282234

PCT Pub. Number WO02/09686

Priority 00/09900 28.07.00 FR

Filing date 26 July 2001

Wipo publication date 13 February 2002

Acceptance publication date 27 July 2006

International Classifications

A61K 31/137 (2006.01) - Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine

A61K 31/381 (2006.01) - having five-membered rings

A61K 31/495 (2006.01) - having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine

C07C 229/36 (2006.01) Compounds containing amino and carboxyl groups bound to the same carbon skeleton

C07C 311/13 (2006.01) Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups

C07C 311/21 (2006.01) Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups

C07C 311/29 (2006.01) Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups

C07C 311/37 (2006.01) Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups

C07D 233/84 (2006.01) Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings

C07D 295/135 (2006.01) Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms

C07D 295/26 (2006.01) Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms

C07D 333/22 (2006.01) Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom

C07D 333/34 (2006.01) Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom

C07F 9/12 (2006.01) Compounds containing elements of the 5th Group of the Periodic System

Event Publications

27 July 2006 Application Accepted

  Published as AU-B-2001282234

23 November 2006 Standard Patent Sealed

12 March 2009 Alteration of Name

  The name of the patentee has been altered to IPSEN Pharma S.A.S 2002

24 February 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001282235

2001282233